BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15753838)

  • 1. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation.
    Land WG
    Transplantation; 2005 Mar; 79(5):505-14. PubMed ID: 15753838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate alloimmunity: history and current knowledge.
    Land W
    Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
    Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
    J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injury to allografts: innate immune pathways to acute and chronic rejection.
    Land WG
    Saudi J Kidney Dis Transpl; 2005; 16(4):520-39. PubMed ID: 18202507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR
    Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation.
    Methe H; Zimmer E; Grimm C; Nabauer M; Koglin J
    Transplantation; 2004 Nov; 78(9):1324-31. PubMed ID: 15548971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor-4 and allograft responses.
    Samstein B; Johnson GB; Platt JL
    Transplantation; 2004 Feb; 77(3):475-7. PubMed ID: 14966433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
    Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
    Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of innate immunity in organ transplantation: part I: evolution of innate immunity and oxidative allograft injury.
    Land WG
    Transplant Rev (Orlando); 2012 Apr; 26(2):60-72. PubMed ID: 22000662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.
    Zhai Y; Shen XD; O'Connell R; Gao F; Lassman C; Busuttil RW; Cheng G; Kupiec-Weglinski JW
    J Immunol; 2004 Dec; 173(12):7115-9. PubMed ID: 15585830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG
    Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury primes the innate immune system for enhanced Toll-like receptor reactivity.
    Paterson HM; Murphy TJ; Purcell EJ; Shelley O; Kriynovich SJ; Lien E; Mannick JA; Lederer JA
    J Immunol; 2003 Aug; 171(3):1473-83. PubMed ID: 12874240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of toll-like receptors in liver transplantation.
    Howell J; Gow P; Angus P; Visvanathan K
    Liver Transpl; 2014 Mar; 20(3):270-80. PubMed ID: 24243591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection.
    Goldstein DR; Tesar BM; Akira S; Lakkis FG
    J Clin Invest; 2003 May; 111(10):1571-8. PubMed ID: 12750407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity and organ transplantation: the potential role of toll-like receptors.
    Andrade CF; Waddell TK; Keshavjee S; Liu M
    Am J Transplant; 2005 May; 5(5):969-75. PubMed ID: 15816875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of Toll-like receptors in allogeneic islet transplantation.
    Ro H; Hong J; Kim BS; Lee EW; Kim MG; Han KH; Yeom HJ; Lee EM; Jeong JC; Oh KH; Ahn C; Yang J
    Transplantation; 2012 Nov; 94(10):1005-12. PubMed ID: 23169223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the innate immune system by the endogenous ligand hyaluronan.
    Shirali AC; Goldstein DR
    Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.